Child pages
  • Serial Non-contrast Non-gated T2w MRI Datasets of Patient-derived Xenograft Cancer Models for Development of Tissue Characterization Algorithms (PDMR-Texture-Analysis)

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 5 Next »

Summary

This collection contains serial non-contrast non-gated T2w MRI of 18 patient derived xenograft cancer models (518 images) for researchers to develop algorithms using neural networks, and classification techniques to improve tissue characterization (morphological changes) for the improvement in patient care through advances in precision medicine.

Characterization of tissue using non-invasive in vivo imaging techniques is used for detection and measurement of disease burden in oncology. Researchers have developed numerous algorithms, such as neural networks, and classification techniques to improve the characterization (morphological changes) of tissue. Unfortunately, to obtain statistical significance, large datasets are a requirement in this research endeavor due to tumor heterogeneity within the same histologic classification. Pre-clinical patient derived xenograft animal models can be a significant resource by providing collections with a more homogenous tumor genome across the collection with companion genomic and pathologic characterization available (https://pdmr.cancer.gov/), allowing determination of the variability of imaging characteristics.

This dataset of a patient derived xenograft models (below tables) can be used for training algorithms for evaluating variations in tissue texture with respect to tumor growth and cancer model.

Patient ID CTEP SDC Description 

Patient ID

CTEP SDC Description

PDMR Web link

144126-210-T

Neuroendocrine Cancer, NOS

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:3466,5509

146476-266-R

Urothelial/Bladder Cancer, NOS

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:1644,2836

165739-295-R

Adenocarcinoma-Pancreas

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:445,700

172845-121-T

Adenocarcinoma-Colon

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:186,202

172845-142-T

Adenocarcinoma-Colon

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:186,213

287954-098-R

Ewing sarcoma/Peripheral PNET

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:856,1664

466636-057-R

Adenocarcinoma-Pancreas

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:721,1330

521955-158-R4

Adenocarcinoma-Pancreas

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:3228,5141

521955-158-R6

Adenocarcinoma-Pancreas

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:3228,5143

625472-104-R 

Adenocarcinoma-Colon

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:875,1715

695669-166-R

Melanoma

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:1106,2151

698357-238-R

Osteosarcoma

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:1516,2696

765638-272-R

Squamous Cell Lung Carcinoma

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:389,590

779769-127-R

Adenocarcinoma-Rectum

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:944,1875

833975-119-R

Adenocarcinoma-pancreas

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:236,302

894883-131-R

Squamous Cell Carcinoma-Anus

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:951,1913

997537-175-T

Adenocarcinoma-Colon

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:3301,5260

BL0382-F1232

Urothelial/bladder cancer, NOS

https://pdmdb.cancer.gov/web/apex/f?p=101:4:::NO:4:P4_PATIENTSEQNBR,P4_SPECIMENSEQNBR:12,12


Biweekly imaging session Characterization 





Characterization

1

2

3

4

5

6

7

8

Patient ID

CTEP SDC Description

Implant Date

Passage

Gender

# Mice imaged per biweekly imaging session

144126-210-T

Neuroendocrine Cancer, NOS

2/14/2020

4

M

8

8

5

5

5

5



146476-266-R

Urothelial/Bladder Cancer, NOS

2/3/2020

4

M

17

16

13

10

11

4

5


165739-295-R

Adenocarcinoma-Pancreas

5/4/2018

2

M

10

10

1






172845-121-T

Adenocarcinoma-Colon

10/16/2020

4

F

20

20







172845-142-T

Adenocarcinoma-Colon

8/24/2018

3

F

15

13

8

3





287954-098-R

Ewing sarcoma/Peripheral PNET

3/18/2021

6

M

10

8

1

1

1




466636-057-R

Adenocarcinoma-Pancreas

12/15/2017

N/A

M

5

5

3

2





521955-158-R4

Adenocarcinoma-Pancreas

9/30/2021

4

F

10

10

10

8

5

1

1


521955-158-R6

Adenocarcinoma-Pancreas

3/27/2018

N/A

F

7

7

4






625472-104-R 

Adenocarcinoma-Colon

8/27/2019

2

F

9

1







695669-166-R

Melanoma

4/16/2021

3

M

7

8

8

6

4

4

2


698357-238-R

Osteosarcoma

3/5/2021

6

F

7

4







765638-272-R

Squamous Cell Lung Carcinoma

3/26/2021

4

F

7

8

5

3

1




779769-127-R

Adenocarcinoma-Rectum

2/19/2020

5

F

5

5

5

5

3

4



833975-119-R

Adenocarcinoma-pancreas

10/23/2019

2

F

12

12

11

7





894883-131-R

Squamous Cell Carcinoma-Anus

2/25/2022

5

F

6

6

6

1

1




997537-175-T

Adenocarcinoma-Colon

10/25/2018

3

M

9

2







BL0382-F1232

Urothelial/bladder cancer, NOS

5/20/2020

4

F

9

6

4

1

1





In this study we performed non-contrast non-gated T2w MRI (SOP50101), initiated 2 weeks post implantation, and continued biweekly imaging sessions until their tumors reached a size requiring humane termination (ACUC guidance > 2 cm in any linear dimension by caliper or MRI measurement) or their clinical status required euthanasia. Fragments (2x2x2 mm3) from the NCI/DCTD PDMR repository are implanted into 5-10 donor mice (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG)). When tumors reach enrollment criteria (100 – 300 mm3), tumors are excised, cut into 2x2x2 mm3 fragments and implanted with Matrigel (per PDMR SOP50101) into NSG study mice. The multi-mouse non-gated DICOM dataset was split according to Tomography. 2021 Feb 5;7(1):1-9. doi: 10.3390/tomography7010001. eCollection 2021 Mar. PMID: 33681459 and retained their individual mouse DICOM header information.

The genomic and pathologic characteristics of these models, which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), can be used in conjunction with this publicly available dataset to guide the development of algorithms for enhanced characterization of tissue for precision medicine.

This collection contains serial non-contrast T2w MRI of 18 patient derived xenograft cancer models (518 images) for researchers to developed various algorithms using neural networks, and classification techniques to improve tissue characterization (morphological changes). The genomic and pathologic characteristics of these models, which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), can be used in conjunction with this publicly available dataset to guide their development of algorithms for enhanced characterization of tissue for precision medicine.

Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • Frederick National Laboratory for Cancer Research – Special Thanks to Joseph D. Kalen, PhD, Lilia V. Ileva, MS, Lisa A Riffle, Nimit Patel, Keita Saito, PhD, Yvonne Evrard, PhD, Elijah Edmondson, DVM, PhD, Jessica Phillips, Simone Difilippantonio, PhD, Chelsea Sanders, Amy James, Lia Thang, Ulrike Wagner, Yanling Liu, PhD, John B. Freymann, and Justin Kirby.
  • Division of Cancer Therapeutics and Diagnosis/National Cancer Institute - James L. Tatum, MD, Paula M Jacobs, PhD, Melinda G. Hollingshead, DVM, and James H. Doroshow, MD
  • PixelMed Publishing – Special Thanks to David A. Clunie, MD
  • University of Arkansas for Medical Sciences – Special Thanks to Kirk E. Smith
  • This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261201500003I. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Data Access

Data TypeDownload all or Query/FilterLicense

Images (DICOM, XX.X GB)


   

(Download requires NBIA Data Retriever)

Click the Versions tab for more info about data releases.

Additional Resources for this Dataset

The National Cancer Institute (NCI) has developed a national repository of Patient-Derived Models (PDMs) comprised of patient-derived xenografts (PDXs), in vitro patient-derived tumor cell cultures (PDCs) and cancer associated fibroblasts (CAFs) as well as patient-derived organoids (PDOrg). These models serve as a resource for public-private partnerships and for academic drug discovery efforts. These PDMs are clinically-annotated with molecular information and made available in the Patient-Derived Model Repository. Data related to the specific subjects in this Collection can be found at:

The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.

Detailed Description

Image Statistics

Radiology Image StatisticsPathology Image Statistics

Modalities



Number of Patients



Number of Studies



Number of Series



Number of Images



Images Size (GB)

Citations & Data Usage Policy

Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution should include references to the following citations:

Data Citation

DOI goes here. Create using Datacite with information from Collection Approval form

Publication Citation


TCIA Citation

Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., Tarbox, L., & Prior, F. (2013). The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository. In Journal of Digital Imaging (Vol. 26, Issue 6, pp. 1045–1057). Springer Science and Business Media LLC. https://doi.org/10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.

Version X (Current): Updated 2023/mm/dd

Data TypeDownload all or Query/FilterLicense

Images (DICOM, XX.X GB)


    (Download requires the NBIA Data Retriever)



  • No labels